key: cord-0826620-wf8ux4oa authors: Dourmishev, Lyubomir; Guleva, Dimitrina title: Ultraviolet diagnostic and treatment modalities in COVID-19 pandemic date: 2021-02-01 journal: Clin Dermatol DOI: 10.1016/j.clindermatol.2021.01.012 sha: 7659d5fe6cc94e73eedee6a2b8551e50221f991f doc_id: 826620 cord_uid: wf8ux4oa Ultraviolet (UV) therapy is an effective and well tolerated therapeutic method for various dermatologic conditions due to its antiproliferative and immunosuppressive effects. Contemporary phototherapy (PhT) includes broadband UVB, narrowband UVB, UVA1, PUVA and excimer laser therapy. The coronavirus disease 2019 (COVID-19) pandemic has resulted in the closure of many patient care facilities including phototherapy units world-wide. Home phototherapy, thalassotherapy, another UV-therapy modalities are an alternative for many patients with chronic dermatoses. We have highlighted possible interactions of UV-therapy effects and the COVID-19 pandemic and have focused on organization and measures against transmission of infections in phototherapy units. Dermatology departments have reopened their units, assessing the risks and benefits for patients, optimizing safety regulations, and adhering to the rules for disinfection. Ultraviolet (UV) therapy is a uniform, highly effective, and well tolerated treatment for various chronic dermatoses, such as alopecia areata, atopic dermatitis, cutaneous T-cell lymphomas (CTCL), graft versus host disease, morphea, psoriasis, prurigo nodularis, scleredema adultorum, and vitiligo. 1 worldwide. 3 The disease fatality rate is several times higher than in influenza, and the leading cause of death is due to acute respiratory distress syndrome induced by proinflammatory responses and oxidative stress. 4 In the days of the pandemic, it is very difficult to manage treatment options in patient with chronic dermatologic conditions. With the closing of many dermatology departments, including their phototherapy units, patients with several dermatoses were lacking suitable therapy. It is well known that UVC radiation, with intensity of 3.75mW/cm 2 for 60 seconds, is capable of inactivating the SARS-CoV-2 virus and interrupting viral RNA transcription, translation, and replication. 5 This method is widely used for disinfection of respirator masks and shields, as well as other personal protective equipment. 6 Other UVC-based germicidal applications include robot-controlled surface disinfection in hospitals and microbial inactivation of food. 7 UVB light is also listed as a promising candidate as a UV germicidal alternative. UVB therapeutic devices are available in many dermatologic offices and departments worldwide; however, not enough data for its effectiveness exist to date. 7 High dose UV radiation degrades polymer materials, which may reduce the efficacy and protection capacity of the respirators disinfected by this method. 8 One of the pathologic effects of the SARS-CoV-2 virus is alterations of the hematopoietic system and hemostasis, causing an accumulation of iron ions in the bloodstream. Iron deposition is able to induce an inflammatory process corresponding with an increase of C-reactive protein, albumin, and lactate dehydrogenase. 9 , 10 The ORF8 and other COVID-19 surface glycoproteins can bind to porphyrin and thus form protoporphyrin that affects hemoglobin transport ability. 11 After the in vitro absorption of photons increases the stability of the iron ion bond with the pyrrolic ring of hemoglobin molecule, preventing the heme from losing its oxygen transport function. 12 Because porphyrins have an absorption peak at 640 nm and the peak absorption of HbO 2 is centered on 900 nm, the irradiation of COVID-19 patients with near-infrared region light with a spectrum between 630 nm and 1000 nm has been proposed as a promising therapeutic method. 11 . This method is in a clinical trial for bacterial pneumonia as well. 13 A recent photodynamic method proposes an illumination of the target lung tissue with lowpower light via fiberoptic catheter, combined with systemic infusion of porphyrin-based photosensitizers. 14 Photodynamic therapy generates highly reactive oxygen singlet, capable of destroying the bonded SARS-CoV-2 viruses and decreasing the viral load in the zone of photoactivation. 14 The irradiation of UV light on the skin produces vitamin D, which absorbs UVB radiation at a spectrum between 290 and 315 nm, a process essential for its activation. Vitamin D has potent anti-inflammatory activities due to the inhibition of interleukin (IL)-1, IL-6, IL-17, tumor necrotic factor (TNF) α and interferon (INF) γ production; other proinflammatory pathways may be involved. 15 Vitamin D also increases innate cellular immunity by inducing antimicrobial peptides, including human cathelicidin LL-37 and defensins. 16 Recent investigations suggest that vitamin D can also modulate IL-6, which appears to be increased in COVID-19 infections. 17 Statistical analysis represents a significant correlation between death rates and a country's geographic latitude, supporting the beneficial effect of sunlight. 18 In contrast, the limited sunlight exposure explains that 75% of institutional indoor populations have a marked vitamin D deficiency and represent increased COVID-19 mortality. 19 Decreased vitamin D levels in winter possibly facilitates viral epidemics; vitamin D supplementation could reduce the incidence, severity, and risk of them. 20 The mortality rate in COVID-19 infection is significantly reduced after peroral vitamin D supplementation. 21 The higher incidence of sunlight is directly related to an increase in the ambient temperature on the Earth's surface. Statistical analyses for China and United States have found a relationship between the transmissibility of COVID-19 and the temperature and humidity. An increase in one-degree Celsius in temperature reduces the effective reproductive number of COVID-19 by 2.3% in China and 2% in the U.S. 22 The same correlation was found for the increased humidity; 20 however, only climate factors alone cannot reduce the effective reproductive number of COVID-19 below one. Even in summer, epidemiologic measures are essential to diminish the transmission of COVID-19. 20 The main effects of UV on skin include immunomodulatory ones with a prevalence of immunosuppression, induction of apoptosis, and modification of dermal collagen metabolism. UV-light induced immunosuppression can increase a patient's susceptibility to various viral infections, including COVID-19. Both UVA and UVB radiation suppress contact hypersensitivity and delayed-type hypersensitivity to viral, bacterial, and fungal antigens in mice. 23 Ultraviolet irradiation intensifies blood flow and infiltration from the blood of macrophages and neutrophils into the skin, resulting in clinically observed inflammation and increased production of nitric oxide. 24 Phototests and photopatch tests (PPT) are valuable for an evaluation of various photodermatoses. Phototesting includes determination of the minimal erythema dose (MED) towards UVA and UVB, immediate pigment darkening dose to UVA and minimal melanogenic doses. The Fitzpatrick's skin phototype classification could to be unreliable in assessing the skin response to UV, because dose ranges in phototype III, IV and V may overlap. 30 The exact PhT course needs an initial MED test. The diagnosis of photosensitive drug eruptions is based on the history of drug intake and the appearance of the eruption on sun-exposed areas. The diagnostic methods include photo testing, photo patch testing, and rechallenge testing. 31 PPT is used for detecting of photoallergic reactions to specific agents among which are sunscreens and medications, such as the nonsteroidal anti-inflammatory drugs. 32 It combines two techniquesa patch testing and long wave UVA exposure with 50-75% of the MED dose and is capable of distinguishing photoallergic from phototoxic reactions. In exceptional cases, UVB irradiation is needed to prove photosensitivity, for example, systemic photosensitivity due to ambroxol. 33 There are no uniform clinical recommendations for management of phototherapy during the COVID-19 pandemic exist. The British Photodermatology Group (BPG) has recommended a plan of action in phototherapy units: 34 All patients should be initially screened for COVID-19 disease and be assessed for the risk of disease aggravation, so PhT could be performed in case of a marked necessity. Phototherapy capacity has to be limited, with priority given to those with severe skin disease urgently requiring treatment. According to SGDI protocols, all vitiligo patients should discontinue therapy and remain on local treatment with tacrolimus. 29 Patients with psoriasis maintain the NB UVB therapy only if the PASI score is more than 10, while those with PASI<10 are switched to topical corticosteroids and/or keratolytics. 29 All scleroderma patients on UVA1 are also switched to local treatment, while severe atopic dermatitis and CTCL patients may continue NB UVB therapy. 29 Measures should be taken to minimize the risk of patients with confirmed or suspected COVID-19 attending the phototherapy units. Social distancing and minimal waiting times with 30 minutes interval between appointments have to be set. The appointments should be adjusted according to operational time for cleaning of the contact parts of equipment between every patient entrance. Patients visiting the service the next day should be questioned by a phone call for fever, flu-like symptoms, contact with patients confirmed or in quarantine for COVID-19, or recent trips to other high-risk countries. 32 Minimal therapeutic courses and measures to minimize treatment duration have to be done. Our experience shows that for the effective treatment of psoriasis, the shortest course has to be at least 10 procedures, during a three-week period. 35 At that time, the risk of contact and the development of unmanifested or oligosymptomatic COVID-19 infection is real. Pre-treatment evaluation of MED for the most appropriate initial dose have to be evaluated, as it is time consuming. A regimen with fixed initial dose according to patient prototype should be used instead. If doses are too low, then patients may need more sessions and a longer lasting course. 32 Both phototherapy staff and patients have to take all measures for self-protection. This plan includes wearing of protective masks, shields, gloves and strict disinfection of machines before and after every patient. Patients have to wearing facial masks before entering the PhT unit and will remove them when he/she is alone. Only one person should have PhT in a room at same time. If a child is treated, only one relative may accompany him/her. Phototherapeutic units tend to be closed in seasons with high outdoor sunlight. In some counties in summer, thalassotherapy is a concurrent option. Bulgarian dermatology is a pioneer in thalassotherapy and in high mountain climate therapy for treatment of psoriasis, vitiligo, and atopic dermatitis. 36, 37 In other countries, such as the USA, home phototherapy is available and should be considered as an option. 38 In regions that offer phototherapy in many locations, reintroduction of phototherapy may initially be more centralized to reduce patient travelling. Peripheral centers should plan to restart phototherapy when possible. 32 The following recommendations are based on the consensus opinion of members of the dermatology expert committee of the Light Treatment Effectiveness (LITE) study, a pragmatic trial of home vs office NB UVB phototherapy to balance risks and benefit for patients and to optimize safety for staff. Once a decision to initiate or to resume phototherapy service has been made, the following recommendations should be given for all patients 39 : :  Screened for COVID-19 symptoms based on local guidelines, before entering the unit;  Attend the phototherapy appointment alone (i.e., family members, friends, caregivers should not enter the medical facility);  Wear a face mask with the exception during the total body phototherapy treatment;  Apply a hand sanitizer upon entering and leaving the unit;  Be provided with individual goggles (if the face is exposed during phototherapy) that can be stored in the unit in an individualized plastic bag. Patients should clean the goggles according to manufacturer's instructions thoroughly with disinfecting wipes before putting them into a bag;  Be given a bag to store their clothes when they disrobe bag to be discarded at the end of treatment;  Practice social distancing. Staff should consider to: Phototherapy in dermatology: A call for action UV-based therapy World Health Organization (WHO) Coronavirus disease COVID-19: consider cytokine storm syndromes and immunosuppression Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation UV-C decontamination for N95 emergency reuse: Quantitative dose validation with photochromic indicators Ultraviolet-based biophotonic technologies for control and prevention of COVID-19, SARS and related disorders Ultraviolet germicidal irradiation: Possible method for respirator disinfection to facilitate reuse during the COVID-19 pandemic Hematological findings and complications of COVID-19 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study COVID-19: attacks the 1-Beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism Photobiomodulation: Shining Light on COVID-19 Comparação do LED Infravermelho comparado às manobras de fisioterapia respiratória no tratamento da pneumonia comunitária Photodynamic and Sonodynamic Therapy of Acute Hypoxemic Respiratory Failure in Patients with COVID-19 Investigation of 20S-hydroxyvitamin D3 analogs and their 1alpha-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities Vitamin D and respiratory infection in adults Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management? COVID-19 fatalities, latitude, sunlight, and vitamin D The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality The interplay between vitamin D and viral infections Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths High temperature and high humidity reduce the transmission of COVID-19 Exposure to low dose UVB light suppresses delayed type hypersensitivity to herpes simplex virus in mice Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis Epidermal Langerhans cells are not required for UVinduced immunosuppression Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs Risk assessment of UVB effects on resistance to infectious diseases Phototherapeutic approach to dermatology patients during the 2019 coronavirus pandemic: real-life data from the Italian red zone The effect of pre-phototest sun exposure on minimal erythema dose and minimal melanogenic dose among skin phototypes III, IV and V Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management Photopatch and UV-irradiated patch testing in photosensitive dermatitis Photosensitivity with eosinophilia due to ambroxol and UVB BPG Statement Regarding Phototherapy Services During Corona Virus Pandemic Correlation of disease activity and quality of life in patients with psoriasis after NB UVB therapy Uber die Behandlung der Vitiligo Thalassotherapie von Hautkrankheiten in Bulgarien (30-jährige Erfahrung) Home phototherapy for patients with vitiligo: challenges and solutions Recommendations for phototherapy during the COVID-19 pandemic